YK
Young Ae Kang

Publications (1)

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial
Article scientifique · 2019

Domaines principaux

Sciences de la santé1

Statistiques

Consultations2
Téléchargements0